The prognostic value of maturation-associated phenotypic abnormalities in myelodysplastic syndromes

被引：12

作者：

Lorand-Metze, I. ^{[1
]}

Califani, S. M. V. ^{[1
]}

Ribeiro, E. ^{[1
]}

Lima, C. S. P. ^{[1
]}

Metze, K. ^{[1
]}

机构：

[1] Univ Estadual Campinas, Fac Med, BR-13081970 Campinas, SP, Brazil

来源：

LEUKEMIA RESEARCH | 2008年 / 32卷 / 02期

基金：

巴西圣保罗研究基金会;

关键词：

myelodysplastic syndromes; cell maturation; phenotypic aberrations; flow cytometry; prognosis;

D O I：

10.1016/j.leukres.2007.06.014

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Several phenotypic abnormalities of bone marrow (BM) hemopoietic precursors have been associated with disease progression in myelodysplastic syndromes (MDS). We analyzed the influence on overall survival of the expression of lineage and maturation-associated antigens of BM hemopoietic cells quantified in a previous study. In the univariate Cox regression the peripheral platelet count was a significant favourable factor for overall survival. Unfavorable prognostic factors were: WPSS, increase in BM CD34+ cells, increased mean fluorescence intensity (MFI) of CD13 on myelocytes, metamyelocytes and mature neutrophils as well as increased CD45 of myelocytes and mature neutrophils. In a model containing platelet count, WPSS and MFI of CD45 and CD13 on mature neutrophils, only hyperexpression of CD13 and degree of thrombocytopenia were independent risk factors. Therefore, phenotypic features that can also be obtained from PB might be useful for predicting Survival in MDS. (C) 2007 Elsevier Ltd. All rights reserved.

引用

页码：211 / 213

页数：3

共 50 条

[31] Prognostic implications in myelodysplastic syndromes: A review of 62 cases [J].

Higuchi, T ;

Mori, H ;

Niikura, H ;

Omine, M ;

Fujita, K .

LEUKEMIA & LYMPHOMA, 1996, 21 (5-6) :479-484

[32] Clinical implications of immunophenotypic abnormalities of bone marrow myeloid cell compartment in myelodysplastic syndromes [J].

Marisavljevic, D. ;

Kraguljac-Kurtovic, N. .

JOURNAL OF BUON, 2010, 15 (04) :746-752

[33] Improving Prognostic Modeling in Myelodysplastic Syndromes [J].

Aziz Nazha ;

Mikkael A. Sekeres .

Current Hematologic Malignancy Reports, 2016, 11 :395-401

[34] Apoptosis and prognostic factors in myelodysplastic syndromes [J].

Shimazaki, K ;

Ohshima, K ;

Suzumiya, J ;

Kawasaki, C ;

Kikuchi, M .

LEUKEMIA & LYMPHOMA, 2002, 43 (02) :257-260

[35] Improving Prognostic Modeling in Myelodysplastic Syndromes [J].

Nazha, Aziz ;

Sekeres, Mikkael A. .

CURRENT HEMATOLOGIC MALIGNANCY REPORTS, 2016, 11 (06) :395-401

[36] Prognostic classification in myelodysplastic syndromes. [J].

Sanz, GF ;

Morel, P .

PATHOLOGIE BIOLOGIE, 1997, 45 (08) :617-626

[37] Classification and Prognostic Evaluation of Myelodysplastic Syndromes [J].

Cazzola, Mario ;

Della Porta, Matteo G. ;

Travaglino, Erica ;

Malcovati, Luca .

SEMINARS IN ONCOLOGY, 2011, 38 (05) :627-634

[38] Detection of hematopoietic maturation abnormalities by flow cytometry in myelodysplastic syndromes and its utility for the differential diagnosis with non-clonal disorders [J].

Lorand-Metze, Irene ;

Ribeiro, Elisangela ;

Lima, Carmen S. P. ;

Batista, Lilia Suarez ;

Metze, Konradin .

LEUKEMIA RESEARCH, 2007, 31 (02) :147-155

[39] Somatic mutations and epigenetic abnormalities in myelodysplastic syndromes [J].

Itzykson, Raphael ;

Kosmider, Olivier ;

Fenaux, Pierre .

BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY, 2013, 26 (04) :355-364

[40] Prognostic impact of somatic mutations and additional chromosomal abnormalities in patients with myelodysplastic syndromes and chromosome 20q deletion [J].

Xinhui Huang ;

Xiao Li ;

Qi Liu ;

Juan Guo ;

Jianan Chen ;

Liyu Zhou ;

Luxi Song ;

Zheng Zhang ;

Jiying Su ;

Yumei Zhang ;

Meng Yan ;

Qi He ;

Dong Wu ;

Feng Xu ;

Chunkang Chang ;

Lingyun Wu .

Clinical and Experimental Medicine, 25 (1)

← 1 2 3 4 5 →